Oversubscribed Share Purchase Plan Successfully Completed
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Impedimed Limited has successfully completed its oversubscribed Share Purchase Plan, raising significant capital from shareholders. The plan closed with applications exceeding the initial target, leading to additional oversubscriptions being accepted by the Board. Participants will receive options alongside their shares, enhancing their investment in the company. An Extraordinary General Meeting is scheduled to approve the issuance of shares and options related to this plan.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallEarlier from Impedimed
- CEO Business Update
- Equity Raising Investor Presentation
- ImpediMed announces a successful $15.2 million Capital Raise
- Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
- ImpediMed Appoints Erik Anderson as Chief Executive Officer
Later from Impedimed
- Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
- Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed